Combined Intrathecal Dexmedetomidine and Adductor Canal Block for Analgesia after Knee Surgeries

Status

Active, not recruiting

Phases

Phase 2

Study type

Interventional

Source

PACTR

Registry ID

PACTR202304775359949

Enrollment

Registered

2023-04-19

Start date

2023-01-15

Completion date

Unknown

Last updated

2026-08-03

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Orthopaedics Anaesthesia

Interventions

Combined intrathecal Dexmedetomidine and Adductor Canal Block

Spinal anesthesia

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: • Patient’s approval. • Age: 30 – 65years. • Sex: Both males and females. • Physical Status: American Society of Anesthesiologists (ASA) I & II.

Exclusion criteria

Exclusion criteria: • Patient refusal • Age: >65 and <30 years. • Allergy to Dexmedetomidine, local anesthetics, systemic opioids and any of the drugs included in the multimodal perioperative pain protocol. • Revision surgery. • Patients with impaired kidney functions and coagulopathy. • Chronic pain syndromes and patients with chronic opioid use defined as use of regular daily doses of systemic narcotics for the past 6 months prior to the surgery. • BMI of 40 or more. • Physical Status: American Society of Anesthesiologists (ASA) III & IV.

Design outcomes

Primary

Measure	Time frame
Visual Analogue Scale (VAS) Scale	—

Secondary

Measure	Time frame
1. Time to first rescue analgesia. 2. Total Morphine consumption in the first 24 hours. 3. Anesthetic complications	—

Countries

Egypt

Contacts

Public ContactMohammad Algyar

Lecturer

dr.mohamedfouad78@gmail.com+201111645345

Outcome results

None listed

Source: PACTR (via WHO ICTRP) · Data processed: Aug 9, 2026